AZ, Daiichi ink co-marketing deal on Nexium

AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) said they have agreed to co-promote and supply the heartburn treatment Nexium in Japan in a deal that includes a $100 million up-front payment to AstraZeneca. Report

Suggested Articles

Amarin Vascepa pill
Marketing

Amarin aims for Vascepa boom with doubled sales team nearly set

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

by Kyle Blankenship
Manufacturing

FDA spanks KVK Tech over impurities in ADHD drug

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

by Eric Palmer
cityscape
Pharma

NICE rejects Roche's new cancer med Polivy on lack of evidence

Data on Roche's Polivy aren't yet enough to win support from England's cost watchdogs, who rejected the medicine based on long-term…

by Eric Sagonowsky